Thomas Clozel, Angel Investor

Thomas Clozel is an angel investor with a focus on AI, biotechnology, and health technology platforms. His portfolio includes Norbert Health, a Series A company developing advanced health monitoring solutions; altrove AI, a seed-stage and pre-seed firm building AI-driven drug discovery tools; and Grâce, a seed-stage company creating digital health solutions for patient care. His other investments include Modern Relay; Callyope; Osium AI; Dioxycle; Resilience; Spot (justspot.io). He invests in companies that advance artificial intelligence, biotechnology innovation, and healthcare ecosystems. Thomas is the CEO and Co-founder of OWKIN, an AI-driven biotech company pioneering biology artificial super intelligence (BASI) for drug discovery and patient care, and serves as Board Director at Bioptimus, reflecting his commitment to scaling AI in life sciences and healthcare.